Table 1 Patient data
Patient | Breed/tumor type | Age (yr) | Gender | Weight (kg) | Capecitabine dosage | Week 5 response |
|---|---|---|---|---|---|---|
Dog 1 | Labrador retriever/ | 12 | M | 41.5 | 791 mg/m\(^2\) | Progressive disease |
squamous cell carcinoma | ||||||
Dog 2 | bulldog mix/ | 8 | FS | 33.9 | 762 mg/m\(^2\) | Progressive disease |
thyroid carcinoma | ||||||
Dog 3 | Labrador mix/ | 8 | MC | 41.0 | 798 mg/m\(^2\) | Stable disease |
anal sac adenocarcinoma | ||||||
Dog 4 | dachshund/ | 12 | MC | 12.8 | 818 mg/m\(^2\) | Stable disease |
perianal carcinoma | ||||||
Dog 5 | rough collie/ | 10 | MC | 43.2 | 772 mg/m\(^2\) | Progressive disease |
urothelial carcinoma |